Initial subject characteristics
| Control group | Ae+RT | Ae only | |
|---|---|---|---|
| n | 9 | 10 | 9 |
| Age (years) | 60.0 ± 2.9 | 63.4 ± 2.2 | 59.4 ± 1.9 |
| Duration of diabetes (years) | 4.7 ± 1.2 | 3.7 ± 0.9 | 3.2 ± 0.6 |
| Number of participants treated with: | |||
| Diet only | 2 | 6 | 6 |
| Single oral agent | 3 | 1 | 2 |
| Two or more oral agents | 4 | 3 | 1 |
| Weight (kg) | 95.6 ± 6.5 | 89.5 ± 3.9 | 81.2 ± 3.8 |
| BMI (kg/m2) | 36.7 ± 2.0 | 33.3 ± 1.5 | 32.5 ± 1.4 |
| Waist circumference (cm) | 119.0 ± 2.1 | 111.1 ± 2.1 | 106.1 ± 2.3 |
| (Vo2 l/min) | 1.75 ± 0.12 | 1.64 ± 0.10 | 1.68 ± 0.11 |
| Glycosylated hemoglobin (%) | 6.9 ± 0.4 | 6.9 ± 0.4 | 6.3 ± 0.2 |
| Glucose infusion rate (mg · kg−1 · min−1) | 2.29 ± 0.46 | 2.36 ± 0.33 | 2.78 ± 0.49 |
| CT | |||
| Total abdominal AT (L4–L5) (cm2) | 808.4 ± 68.0 | 720.0 ± 42.0 | 616.8 ± 41.9 |
| Subcutaneous (cm2) | 549.3 ± 50.8 | 468.9 ± 26.9 | 401.2 ± 42.9 |
| Visceral (cm2) | 259.1 ± 34.4 | 251.1 ± 22.9 | 215.7 ± 25.8 |
| Midthigh skeletal muscle | |||
| Cross-sectional area (cm2) | 225.8 ± 8.9 | 208 ± 10.0 | 224.1 ± 15.8 |
| Low-density muscle (cm2) | 50.6 ± 4.2 | 51.3 ± 6.7 | 49.4 ± 7.3 |
| Normal-density muscle (cm2) | 175.3 ± 7.5 | 156.6 ± 12.8 | 174.8 ± 11.1 |
Data are n or means ± SE.